Our Research

Photo Credit: Dr. James Bayrer


Understanding Intestinal Epithelial Biology

The intestinal epithelium comprises the human body’s greatest environmentally exposed surface and represents the largest sensory and endocrine organ. We utilize intestinal organoids and animal models to understand how the intestine senses and responds to regular and inflammatory stimuli. By investigating the molecular pathways involved, we aim to discover new ways to promote intestinal wound healing and modulate the signals contributing to visceral pain syndromes.


Linking Lipid Ligands With Nuclear Receptor Function

Ongoing research focuses on NR5A nuclear receptors, SF-1 and LRH-1 because of their critical roles in various aspects of metabolism. We are currently working to understand a puzzling question posed by our earlier structural studies – why would phospholipids serve as NR5A ligands. This is being explored for LRH-1 in two model systems, the liver hepatocyte, and the mouse or human intestinal organoid. Efforts are underway to find synthetic ligands that could prove useful in fatty liver disease and inflammatory bowel disease.


Photo Credit: Dr. William Krause


Sex-Dependent Central Regulation of Female Metabolism and Physiology

We are broadly interested in how the female brain uniquely controls a wide-range of sex-specific physiological responses. Currently, we focus on estrogen signaling in the medial basal hypothalamus (MBH) that includes the ventromedial hypothalamus (VMH) and the arcuate nucleus (ARC). Mouse models coupled with genomics and pharmacogenetics are leveraged to define the estrogen-sensitive neuronal modules important in locomotion, thermogenesis, reproduction and bone density. Our research program is highly relevant to age-related diseases in hormone deficient stages and to women’s health. 


Recent Publications

LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity.
Miranda DA, Krause WC, Cazenave-Gassiot A, Suzawa M, Escusa H, Ingraham HA. JCI Insight. March 2018
Xing Y, Morohashi KI, Ingraham HA, Hammer GD. Development. 2017 Sep 11. 
Bellono NW, Bayrer JR, Leitch DB, Castro J, Zhang C, O'Donnell TA, Brierly SM, Ingraham HA, Julius DJ. Cell. June 2017